Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Association between mineral and bone disorder in patients with acute kidney injury following cardiac surgery and adverse outcomes

Fig. 1

Mineral and bone metabolite levels in a subgroup of 71 patients with different stages of AKI. The (a) Scr levels, (b) calcium levels, (c) phosphate levels, (d) iPTH levels, (e) 25D levels, (f) BAP levels, (g) TRACP-5b levels, and (h) cFGF23 levels. --●-- (dot): AKI stage 1 (n = 23); −-▇--(square): AKI stage 2 (n = 24); ▲ (triangle): AKI stage 3 (n = 24). P values are from repeated-measures linear mixed models comparing the 3 groups. *P < 0.05, **P < 0.01, and ***P < 0.001; a comparison of the biomarker levels cross AKI categories at individual time points. The data are shown as the median (interquartile range). Scr: serum creatinine; iPTH: intact parathyroid hormone; 25D: 25-hydroxyvitamin D; BAP: bone-specific alkaline phosphatase; TRACP-5b: tartrate-resistant acid phosphatase 5b; cFGF23: C-terminal fibroblast growth factor 23

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us